The effects of subcutaneous insulin detemir on glucose flux, pharmacokinetics and brain function in type one diabetes
Phase of Trial: Phase IV
Latest Information Update: 01 May 2015
At a glance
- Drugs Insulin detemir (Primary) ; Insulin suspension isophane (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 25 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
- 25 Jun 2013 Status changed from recruiting to completed, based on presentation of results.
- 06 Oct 2011 New trial record